Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$651M |
| 2 |
Monster Beverage
MNST
|
$615M |
| 3 |
Intercontinental Exchange
ICE
|
$556M |
| 4 |
Johnson & Johnson
JNJ
|
$382M |
| 5 |
Applied Materials
AMAT
|
$381M |
Top Sells
| 1 |
Lam Research
LRCX
|
$1.95B |
| 2 |
Texas Instruments
TXN
|
$771M |
| 3 |
Deere & Co
DE
|
$597M |
| 4 |
Meta Platforms (Facebook)
META
|
$543M |
| 5 |
Microsoft
MSFT
|
$510M |
Sector Composition
| 1 | Technology | 34.01% |
| 2 | Healthcare | 19.85% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.48% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Edgewise Therapeutics
EWTX
$1.64B
| $122M | 0.06% |
4,558,519
+1,951,220
| +75% | +$52.1M |
|
252
Carlisle Companies
CSL
$16.9B
| $120M | 0.06% |
266,296
-68,114
| -20% | -$30.6M |
|
253
RTX Corp
RTX
$211B
| $118M | 0.06% |
976,527
+702,699
| +257% | +$85.1M |
|
254
Tesla
TSLA
$1.13T
| $116M | 0.06% |
444,091
+19,342
| +5% | +$5.06M |
|
255
Trip.com Group
TCOM
$47.6B
| $115M | 0.06% |
1,940,993
-16,927
| -0.9% | -$1.01M |
|
256
Alibaba
BABA
$323B
| $115M | 0.06% |
1,081,188
+490,694
| +83% | +$52.1M |
|
257
Janux Therapeutics
JANX
$1.44B
| $115M | 0.06% |
2,523,406
+721,563
| +40% | +$32.8M |
|
258
Gates Industrial
GTES
$6.68B
| $114M | 0.06% |
6,484,706
+7,670
| +0.1% | +$135K |
|
259
UL Solutions
ULS
$12.8B
| $114M | 0.06% |
2,307,651
-20,559
| -0.9% | -$1.01M |
|
260
STAG Industrial
STAG
$6.9B
| $113M | 0.06% |
2,900,765
-562,849
| -16% | -$22M |
|
261
Telus
TU
$25.3B
| $113M | 0.06% |
6,701,819
+49,088
| +0.7% | +$825K |
|
262
89bio
ETNB
$1.32B
| $112M | 0.06% |
15,158,218
+1,882,108
| +14% | +$13.9M |
|
263
Nice
NICE
$8.67B
| $112M | 0.06% |
644,447
-479,448
| -43% | -$83.3M |
|
264
SPX Corp
SPXC
$9.28B
| $111M | 0.06% |
696,713
+217,316
| +45% | +$34.7M |
|
265
Insmed
INSM
$30.7B
| $109M | 0.06% |
1,488,904
-602,874
| -29% | -$44M |
|
266
Maximus
MMS
$4.97B
| $108M | 0.06% |
1,163,439
+1,000
| +0.1% | +$93.2K |
|
|
SUM
267
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $108M | 0.06% |
2,771,481
+2,175
| +0.1% | +$84.9K |
|
268
BellRing Brands
BRBR
$4.97B
| $108M | 0.06% |
1,775,559
+6,951
| +0.4% | +$422K |
|
269
Doximity
DOCS
$13B
| $107M | 0.06% |
2,464,887
-13,662
| -0.6% | -$595K |
|
270
Occidental Petroleum
OXY
$45.2B
| $107M | 0.05% |
2,079,827
-224,967
| -10% | -$11.6M |
|
271
Legend Biotech
LEGN
$6.66B
| $107M | 0.05% |
2,185,634
-173,422
| -7% | -$8.45M |
|
272
Novo Nordisk
NVO
$245B
| $106M | 0.05% |
892,427
-1,170
| -0.1% | -$139K |
|
273
Inspire Medical Systems
INSP
$2.56B
| $106M | 0.05% |
502,609
+27,374
| +6% | +$5.78M |
|
274
Regeneron Pharmaceuticals
REGN
$60.8B
| $103M | 0.05% |
98,134
-2,290
| -2% | -$2.41M |
|
275
Booz Allen Hamilton
BAH
$12.6B
| $103M | 0.05% |
631,703
+146,420
| +30% | +$23.8M |
|